Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carlos Dueñas-Gutierrez"'
Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients
Autor:
David García-Azorín, Enrique Martínez-Pías, Javier Trigo, Isabel Hernández-Pérez, Gonzalo Valle-Peñacoba, Blanca Talavera, Paula Simón-Campo, Mercedes de Lera, Alba Chavarría-Miranda, Cristina López-Sanz, María Gutiérrez-Sánchez, Elena Martínez-Velasco, María Pedraza, Álvaro Sierra, Beatriz Gómez-Vicente, Ángel Guerrero, David Ezpeleta, María Jesús Peñarrubia, Jose Ignacio Gómez-Herreras, Elena Bustamante-Munguira, Cristina Abad-Molina, Antonio Orduña-Domingo, Guadalupe Ruiz-Martin, María Isabel Jiménez-Cuenca, Santiago Juarros, Carlos del Pozo-Vegas, Carlos Dueñas-Gutierrez, Jose María Prieto de Paula, Belén Cantón-Álvarez, Jose Manuel Vicente, Juan Francisco Arenillas
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Introduction: Prognosis of Coronavirus disease 2019 (Covid-19) patients with vascular risk factors, and certain comorbidities is worse. The impact of chronic neurological disorders (CND) on prognosis is unclear. We evaluated if the presence of CND in
Externí odkaz:
https://doaj.org/article/b0159c5e0ff741fdba0165ced01c01a6
Autor:
Carlos Dueñas Gutierrez, Jesica Abadia-Otero, Ivan Cusacovich, Jose Ignacio Martín-González, Alberto Muela-Molinero, Luis Corral-Gudino, Roberto González-Fuentes, Ängela Ruíz de Temiño, Elena Tapia Moral, Francisca Cuadrado-Medina, Miguel Martín-Asenjo, Pablo Miramontes Gonzalez, Jose Luis Delgado Morales, Sandra Ines, Laura Abad-Manteca, Iciar Usategui-Martín, Tomás Ruíz-Albí, Sara Miranda-Riaño, Patricia Rodríguez-Fortúnez, Consuelo Rodríguez-Jiménez, Esperanza López-Franco, Miguel Marcos
Publikováno v:
Open Forum Infectious Diseases. 9
Background Pulse glucocorticoid therapy is used in COVID-19 infection. We evaluated the effectiveness of methylprednisolone 250 mg/d for 3 days vs. dexamethasone 6 mg/d for 10 days in patients with severe but not critical COVID-19 pneumonia. Methods
Autor:
Luis Buzón-Martín, Carlos Dueñas Gutierrez, José Antonio Iribarren, Ignacio de los Santos, Alberto Diaz-De Santiago, Miguel Ángel Morán-Rodríguez, Guillermo Pousada, Claudia González Rico, Estela Moreno García, Eva Ferreira, Alicia Iglesias Gómez, Cristina Martín gómez, Julia gómez Barquero, Miguel V Egido Murciano, Jesús Troya
Publikováno v:
Open Forum Infectious Diseases. 9
Background Dolutegravir-based dual therapies for treating people living with HIV (PLHIV) are strategies strongly recommended in several practice guidelines. The safety and efficacy combination of Dolutegravir (DTG) plus 3TC as a switching strategy in
Autor:
María Begona Coco-Martín, Luis Leal-Vega, Irene Alcoceba-Herrero, Ainhoa Molina-Martín, Dolores de-Fez, María José Luque, Carlos Duenas-Gutiérrez, Juan Francisco Arenillas-Lara, David P. Pinero
Publikováno v:
International Journal of Ophthalmology, Vol 16, Iss 1, Pp 1-9 (2023)
AIM: To compare the visual perception (color and chromatic-achromatic contrast vision) of a small cohort of COVID-19 patients at the time of infection and after 6mo with that of a healthy population matched for sex and age. METHODS: A total of 25 pat
Externí odkaz:
https://doaj.org/article/46549c767a3a4c25a06f8a16845b7f6f
Autor:
Pablo Carbonero-Lechuga, Javier Castrodeza-Sanz, Iván Sanz-Muñoz, Pilar Marqués-Sánchez, Jose M. Eiros, Carlos Dueñas-Gutiérrez, Camino Prada-García
Publikováno v:
Healthcare, Vol 11, Iss 9, p 1299 (2023)
In patients with human immunodeficiency virus (HIV), adherence to treatment is affected by the adverse effects of treatment, the presence of additional comorbidities, the complexity of dosage, and family and community support. However, one recent cir
Externí odkaz:
https://doaj.org/article/47d3054958bc4fccb9ec4d721b1b4de3
Autor:
Carlos Dueñas-Gutiérrez, Luis Buzón, Roberto Pedrero-Tomé, José A. Iribarren, Ignacio De los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya
Publikováno v:
Viruses, Vol 15, Iss 4, p 936 (2023)
Background: The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir (DTG) plus lamivudine (3TC) have led to international guidelines recommending their use for treatment-naive HIV patients. In virologically suppressed pat
Externí odkaz:
https://doaj.org/article/999b575dbb0e492eb9a121410025beff
Autor:
Julio Collazos, Pere Domingo, Nerio Fernández-Araujo, Elia Asensi-Díaz, Helem Vilchez-Rueda, Antonio Lalueza, Emilia Roy-Vallejo, Rosa Blanes, Manuel Raya-Cruz, Jaime Sanz-Cánovas, Arturo Artero, José-Manuel Ramos-Rincón, Carlos Dueñas-Gutiérrez, José Luis Lamas-Ferreiro, Víctor Asensi, Valproic Acid in COVID-19 Study Group
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262777 (2022)
BackgroundValproic acid (VPA) has shown beneficial effects in vitro against SARS-CoV-2 infection, but no study has analyzed its efficacy in the clinical setting.MethodsThis multicenter, retrospective study included 165 adult patients receiving VPA at
Externí odkaz:
https://doaj.org/article/f02585ec915c4415abe1a9f67ad1d733